Ureteral stent, no stent and no stent plus methylprednisolone and alpha blockers in ureteroscopic laser lithotripsy

Manu, M.A.; Parliteanu, B.; Angelescu, E; Prie, I.; Dudu, C.; Surcel, C.; Stefan, B.; Manu, R.; Vlaicu, N.; Cerempei, V.; Sinescu, I.

doi:10.1016/s1569-9056(15)30346-8

Cited by 2 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In all, 14 studies did not meet the inclusion criteria or were not relevant to the question under question. 1,11,[16][17][18][19][20][21][22][23][24][25][26][27] We identified one ongoing trial. 28 In all, 23 studies with 24 relevant articles (abstracts or secondary publications: not listed in the references) ultimately met the inclusion criteria and were included in the qualitative synthesis of this review.…”

Section: Search Resultsmentioning

confidence: 99%

Ureteral stent versus no ureteral stent for ureteroscopy in the management of renal and ureteral calculi: A Cochrane review

Ordonez

Hwang

Borofsky

et al. 2019

CUAJ

View full text Add to dashboard Cite

Introduction: We aimed to assess the effects of postoperative ureteral stent placement after uncomplicated ureteroscopy. Methods: We performed a comprehensive search with no restrictions on publication language or status up to February 1, 2019. We only included randomized trials. Two review authors independently examined full-text reports, identified relevant studies, assessed the eligibility of studies for inclusion, extracted data, and assessed risk of bias. We performed statistical analyses using a random-effects model and assessed the certainty of the evidence according to GRADE. Results: We included 23 studies with 2656 randomized patients. Primary outcomes: It is uncertain whether stenting reduces the number of unplanned return visits (very low CoE). Pain on the day of surgery is probably similar (mean difference [MD] 0.32; 95% confidence interval (CI) -0.13‒0.78; moderate CoE). Pain on postoperative days 1‒3 may show little to no difference (SMD 0.25; 95% CI -0.32‒0.82; low CoE). It is uncertain whether stented patients experience more pain on postoperative days 4‒30 (very low CoE). Stenting may result in little to no difference in the need for secondary interventions (relative risk [RR] 1.15; 95% CI 0.39‒3.33; low CoE). Secondary outcomes: We are uncertain whether stenting reduces the need for narcotics and reduces ureteral stricture rates up to 90 days (very low CoE). Rates of hospital admission may be slightly reduced (RR 0.70; 95% CI 0.32‒1.55; low CoE). This review was limited to patients in whom ureteroscopy was deemed ‘uncomplicated.’ In addition, time intervals for the grouping for the reported degree of pain were established post hoc. The CoE for most outcomes was rated as low or very low for methodological reasons. Conclusions: Findings of this review illustrate the tradeoffs of risks and benefits faced by urologists and their patients when it comes to decision-making about stent placement after uncomplicated ureteroscopy for stone disease.

show abstract

Section: Search Resultsmentioning

confidence: 99%

Ureteral stent versus no ureteral stent for ureteroscopy in the management of renal and ureteral calculi: A Cochrane review

Ordonez

Hwang

Borofsky

et al. 2019

CUAJ

View full text Add to dashboard Cite

show abstract

Ureteral stent versus no ureteral stent for ureteroscopy in the management of renal and ureteral calculi

Ordonez

Hwang

Borofsky

et al. 2019

Cochrane Database of Systematic Reviews

View full text Add to dashboard Cite

Background Ureteroscopy combined with laser stone fragmentation and basketing is a common approach for managing renal and ureteral stones. This procedure is associated with some degree of ureteral trauma. Ureteral trauma may lead to swelling, ureteral obstruction, and flank pain and may require subsequent interventions such as hospital admission or secondary ureteral stent placement. To prevent such issues, urologists often place temporary ureteral stents prophylactically, but the value of doing so remains unclear. Objectives To assess the effects of postoperative ureteral stent placement after uncomplicated ureteroscopy. Search methods We performed a comprehensive search using multiple databases (the Cochrane Library, MEDLINE, Embase, Scopus, Google Scholar, and Web of Science), trials registries, other sources of grey literature, and conference proceedings, up to 01 February 2019. We applied no restrictions on publication language or status. Selection criteria We included trials in which researchers randomised participants undergoing uncomplicated ureteroscopy to placement of a ureteral stent versus no ureteral stent. Data collection and analysis Two review authors independently classified studies and abstracted data from the included studies. We performed statistical analyses using a random-effects model. We rated the certainty of evidence (CoE) according to the GRADE approach. 1 Ureteral stent versus no ureteral stent for ureteroscopy in the management of renal and ureteral calculi (Review)

show abstract

Ureteral stent, no stent and no stent plus methylprednisolone and alpha blockers in ureteroscopic laser lithotripsy

Cited by 2 publications

References 0 publications

Ureteral stent versus no ureteral stent for ureteroscopy in the management of renal and ureteral calculi: A Cochrane review

Ureteral stent versus no ureteral stent for ureteroscopy in the management of renal and ureteral calculi: A Cochrane review

Ureteral stent versus no ureteral stent for ureteroscopy in the management of renal and ureteral calculi

Contact Info

Product

Resources

About